{"id":"xc221","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"XC221 works by binding to the active site of the SARS-CoV-2 main protease, thereby preventing the cleavage of viral polyproteins and ultimately inhibiting viral replication. This mechanism of action is specific to the SARS-CoV-2 virus and is not expected to affect other proteases in the human body.","oneSentence":"XC221 is a small molecule that inhibits the activity of the SARS-CoV-2 main protease.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:41:08.244Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of COVID-19"}]},"trialDetails":[{"nctId":"NCT05544916","phase":"PHASE3","title":"A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections","status":"COMPLETED","sponsor":"Valenta Pharm JSC","startDate":"2022-08-05","conditions":"Influenza, Respiratory Viral Infection","enrollment":260},{"nctId":"NCT04940182","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19","status":"COMPLETED","sponsor":"RSV Therapeutics LLC","startDate":"2021-06-26","conditions":"Sars-CoV-2 Infection","enrollment":274},{"nctId":"NCT05295121","phase":"PHASE1","title":"Study of the Effect of Food Intake on the Bioavailability of XC221 100 mg Tablets","status":"COMPLETED","sponsor":"Valenta Pharm JSC","startDate":"2022-02-10","conditions":"Healthy","enrollment":24},{"nctId":"NCT04487574","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19","status":"COMPLETED","sponsor":"RSV Therapeutics LLC","startDate":"2020-07-25","conditions":"SARS-CoV-2 Infection","enrollment":118},{"nctId":"NCT05030324","phase":"PHASE2","title":"A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections","status":"COMPLETED","sponsor":"Valenta Pharm JSC","startDate":"2021-10-01","conditions":"Influenza, Viral Respiratory Infection, Acute Viral Upper Respiratory Infections","enrollment":255},{"nctId":"NCT03830905","phase":"PHASE2","title":"Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI","status":"COMPLETED","sponsor":"PHARMENTERPRISES LLC","startDate":"2019-01-31","conditions":"Influenza, Acute Respiratory Viral Infections","enrollment":120},{"nctId":"NCT03455491","phase":"PHASE2","title":"Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections","status":"COMPLETED","sponsor":"PHARMENTERPRISES LLC","startDate":"2018-02-12","conditions":"Acute Respiratory Viral Infections, Influenza","enrollment":120},{"nctId":"NCT03459391","phase":"PHASE1","title":"Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers","status":"COMPLETED","sponsor":"PHARMENTERPRISES LLC","startDate":"2017-05-22","conditions":"Influenza, Acute Respiratory Infection","enrollment":32}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"XC221","genericName":"XC221","companyName":"RSV Therapeutics LLC","companyId":"rsv-therapeutics-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"XC221 is a small molecule that inhibits the activity of the SARS-CoV-2 main protease. Used for Treatment of COVID-19.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}